ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Dr. Jim Birchenough Joins Barclays as Co-Head of Global Biopharma Investment Banking

Dr. Birchenough will partner with Alexis de Rosnay, who takes on an expanded role; he also assumes the role of Chairman of Global Healthcare Investment Banking

Barclays today announced the appointment of Jim Birchenough, MD, as Chairman of Global Healthcare Investment Banking and Co-Head of Global Biopharma Investment Banking, based in San Francisco.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230710732855/en/

Alexis de Rosnay, Jim Birchenough (Photo: Business Wire)

Alexis de Rosnay, Jim Birchenough (Photo: Business Wire)

Dr. Birchenough has over 35 years of life science experience across biopharmaceutical bench research, clinical medicine practice, biotech equity research, and biopharma investment banking. He joins Barclays from Wells Fargo, most recently leading their Biopharma Investment Banking franchise. Prior to that, he spent over 20 years as a leading biotech equity research analyst at Wells Fargo, BMO Capital Markets, Barclays and Lehman Brothers, covering both smaller, development-stage biotech and larger, global biopharma companies.

Birchenough will partner with Alexis de Rosnay, who is taking on an expanded role as Co-Head of Global Biopharma Investment Banking, in addition to his existing responsibilities as Chairman of Global Healthcare Investment Banking. Since joining Barclays a year ago, de Rosnay has significantly expanded Barclays’ life sciences franchise and is successfully leading efforts around a broad range of critical client relationships.

“The wealth of experience and extensive client relationships that Jim and Alexis possess, coupled with their strong track records of growing businesses, will be of huge value as we continue to further expand our coverage footprint in the healthcare sector, in particular with biotech and pharma clients,” said Rick Landgarten, Global Head of Healthcare and Real Estate Investment Banking.

About Barclays Corporate and Investment Bank

Barclays Corporate and Investment Bank is comprised of the Investment Banking, International Corporate Banking, Global Markets and Research businesses. It provides money managers, financial institutions, governments, supranational organisations and corporate clients with services and advice for their funding, financing, strategic and risk management needs. For further information about Barclays Corporate and Investment Bank, please visit our website www.cib.barclays.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  245.01
-4.09 (-1.64%)
AAPL  274.29
-0.96 (-0.35%)
AMD  255.24
+17.72 (7.46%)
BAC  54.03
+0.40 (0.75%)
GOOG  286.83
-4.91 (-1.68%)
META  612.16
-14.92 (-2.38%)
MSFT  509.98
+1.30 (0.26%)
NVDA  191.91
-1.25 (-0.65%)
ORCL  227.05
-9.10 (-3.85%)
TSLA  429.54
-10.08 (-2.29%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.